NIH SBIR and STTR funding can help life science, health technology, biotech, medtech, and research-driven companies move promising innovation closer to commercialization. But a strong NIH application requires more than a compelling scientific idea.

 

The budget also needs to make sense.

 

Your NIH SBIR/STTR budget should show that the proposed work is financially realistic, properly supported, and aligned with federal expectations. It should also give your company a structure it can manage after award, from cost tracking and reporting to indirect rates and audit readiness.

 

At Peter Witts CPA PC, we help NIH SBIR/STTR applicants and awardees strengthen the financial side of their proposals so they can pursue funding, manage awards, and grow with confidence.

 

Why NIH SBIR Budget Strategy Matters

For many applicants, the budget is treated as one of the last pieces of the application. The technical narrative receives most of the attention, while the budget is assembled quickly from estimates, assumptions, or prior templates.

 

That can create problems.

 

The NIH budget is not just a formality. It helps reviewers and agency staff understand whether the proposed work is reasonable, whether the company has thought through the required resources, and whether the financial plan can support successful award performance.

 

A strong NIH SBIR/STTR budget should help answer several questions:

• Are the requested costs necessary for the proposed research?
• Are the costs reasonable for the scope of work?
• Are costs properly classified as direct, indirect, or fee?
• Are consultants, subcontractors, and key personnel supported clearly?
• Does the budget align with the project timeline and milestones?
• Can the company track and manage these costs after award?

Budget strategy matters because the decisions you make before submission can shape how the award is managed later.

 

Understand the Three Major Budget Categories

NIH SBIR/STTR budgets generally include three major financial components:

• Direct costs
• Facilities and administrative costs, also called F&A or indirect costs
• Fee or profit, when applicable

Each category serves a different purpose.

 

Direct costs are tied directly to the proposed project. These may include project labor, materials, supplies, consultants, subcontractors, equipment when allowed, travel, and other costs needed to complete the research.

 

F&A or indirect costs support the business more broadly. These may include rent, utilities, administrative support, accounting, insurance, compliance activity, software, and other operating costs that benefit the organization but are not tied to one specific project task.

 

Fee, sometimes referred to as profit, is separate from direct and indirect costs. It can give small businesses more flexibility, but it still needs to be handled correctly within NIH rules and budget limits.

 

A trusted NIH SBIR budget should make these categories clear and supportable.

 

Start With the Work, Then Build the Budget

The best NIH SBIR/STTR budgets start with the research plan, not the spreadsheet.

 

Before assigning dollar amounts, your team should understand the technical aims, project milestones, timeline, personnel needs, outside support, materials, and commercialization goals. The budget should then be built around what the work actually requires.

 

A budget that reviewers can trust should connect clearly to:

• Specific aims and milestones
• Personnel effort
• Consultant and subcontractor roles
• Materials and supplies
• Equipment or specialized services, if needed and allowed
• Project timeline
• Testing, validation, or regulatory-related activities
• Commercialization or follow-on planning, where applicable

The stronger the connection between the work plan and the budget, the easier it is for reviewers to understand why the requested funds are necessary.

 

Allowable Costs: What Applicants Should Think Through

Allowable costs are costs that can be charged to the award under applicable federal and NIH rules. For NIH SBIR/STTR applicants, allowability should be reviewed before submission, not after award.

 

A cost is generally stronger when it is necessary for the project, reasonable in amount, allocable to the work, and supported by documentation.

 

Examples of costs that may appear in an NIH SBIR/STTR budget include:

• Salaries and wages for project personnel
• Fringe benefits
• Consultant costs
• Subaward or research institution costs
• Materials and supplies
• Equipment, when justified and allowed
• Travel related to the project
• Animal studies, lab services, testing, or specialized technical services
• Other direct costs needed to perform the research

The key is not simply whether a cost appears to be related to the project. The company should be able to explain why the cost is needed, how the amount was estimated, and how it will be tracked after award.

 

Avoid Weak or Unsupported Budget Assumptions

A budget can lose credibility when assumptions are vague or unsupported. NIH reviewers and agency staff should not have to guess why a cost is included or how it was calculated.

 

Common weak spots include:

• Personnel effort that does not clearly match the work plan
• Consultant costs without a clear role or basis
• Subcontractor costs without enough detail
• Equipment requests that are not clearly justified
• Indirect rates that are not supported
• Travel costs that are not tied to project needs
• Budget narratives that repeat numbers without explaining them
• Costs that do not align with the project timeline

A strong budget narrative should explain the financial logic behind the numbers. It should help the reviewer understand how the requested funds support the scientific and commercial goals of the project.

 

The Role of Fee in NIH SBIR/STTR Budgets

Fee is one of the areas SBIR/STTR applicants often overlook or misunderstand.

 

Unlike direct costs, fee is not tied to a specific project expense. It can provide small businesses with additional flexibility, which can be especially important for early-stage companies managing research, operations, and commercialization planning.

 

However, fee should still be budgeted carefully and in accordance with NIH guidance and the specific funding opportunity. It should not be treated as an afterthought or confused with indirect costs.

 

When thinking about fee, applicants should ask:

• Is fee allowed under this opportunity?
• How does fee fit within the total budget limit?
• Is the fee calculated correctly?
• Is the company clearly distinguishing fee from direct and indirect costs?
• Has the budget been reviewed against NIH instructions?

Fee can be helpful, but only when it is handled correctly inside the overall budget strategy.

 

Indirect Rates: Why They Matter for NIH SBIR/STTR Applicants

Indirect costs are often one of the most important financial planning areas for NIH SBIR/STTR companies.

 

Many early-stage companies underestimate the real operating costs required to support federally funded research. Administrative time, accounting, payroll, compliance, facilities, software, insurance, and management support all have a cost. If those costs are not planned properly, the company may underfund the infrastructure needed to manage the award.

 

Your indirect rate strategy can affect:

• How much of your operating cost is recovered
• Whether the budget is financially sustainable
• How clearly the company can support costs after award
• How the accounting system should be structured
• Whether the budget is ready for future Phase II or follow-on funding

A company with a negotiated indirect cost rate agreement may use that approved rate, if applicable. A company without a negotiated rate may need to use an estimated rate with supporting documentation or another allowable approach based on NIH guidance and the funding opportunity.

 

The most important point is this: your indirect rate should reflect your company’s own financial structure. It should not be copied from another applicant or guessed at the last minute.

 

NIH’s 40% F&A Threshold for SBIR/STTR

NIH guidance continues to allow SBIR/STTR recipients to recover F&A costs up to 40% of total direct costs, unless a negotiated indirect cost rate agreement applies or the specific award terms require a different treatment.

 

This does not mean every company should automatically use 40%.

 

The rate should still be reasonable, supportable, and connected to the company’s actual or projected costs. For some companies, a lower rate may be more appropriate. For others, a more formal negotiated rate may be needed as federal funding grows.

 

Before choosing an indirect rate, applicants should consider:

• What indirect costs the company actually incurs
• Whether the rate can be supported with financial records or projections
• Whether the accounting system can track indirect costs properly
• How the rate affects proposal competitiveness
• Whether the rate will support award performance
• How the rate may need to evolve for Phase II or future awards

The goal is not simply to maximize the budget. The goal is to create a financial structure that is realistic, defensible, and aligned with how the company will manage the award.

 

Connect the Budget to the Accounting System

An NIH SBIR/STTR budget should be manageable after award. If the company cannot track the costs the way the proposal presents them, problems can appear later in reporting, drawdowns, reconciliations, or agency review.

 

Before submitting, applicants should ask:

• Can our accounting system track costs by project or award?
• Can it separate direct, indirect, and unallowable costs?
• Can it support labor distribution and timekeeping?
• Can it produce budget-to-actual reports?
• Can it support drawdowns and financial reporting?
• Can it maintain documentation for consultants, subcontractors, payroll, and vendors?
• Can it reconcile indirect costs to the rate used in the budget?

A budget that looks strong on paper should also work inside the company’s accounting system.

 

Plan for Phase II Before Phase I Ends

NIH SBIR/STTR funding is often part of a longer development path. A Phase I budget may be smaller and more focused, but Phase II usually brings greater funding, longer timelines, more personnel, more vendors, and more financial complexity.

 

That means the budget strategy should not only address the current application. It should consider where the company is going.

 

Companies preparing for NIH SBIR/STTR funding should think about:

• Whether the current accounting system can scale
• Whether indirect rates will need to be refined
• Whether timekeeping processes are ready
• Whether subcontractor and consultant tracking will become more complex
• Whether internal reporting is strong enough for leadership decisions
• Whether the company can support future audits or agency questions
• Whether the financial plan supports commercialization milestones

A stronger budget strategy can help the company move from proposal submission to award management with fewer surprises.

 

Common NIH SBIR Budget Mistakes

NIH SBIR/STTR applicants often run into issues when the budget is built too quickly or without enough financial review.

 

Common mistakes include:

• Treating the budget as an administrative form instead of a strategy tool
• Using unsupported salary or effort assumptions
• Misclassifying direct and indirect costs
• Forgetting to include administrative or compliance costs
• Using another company’s indirect rate
• Assuming 40% F&A is always the right rate
• Confusing fee with indirect costs
• Providing weak budget justification language
• Failing to align subcontractor or consultant costs with the work plan
• Building a budget that the accounting system cannot track after award

These mistakes can weaken proposal credibility and create post-award management challenges.

 

Final Thoughts: A Strong NIH SBIR Budget Supports the Science

NIH SBIR/STTR funding is designed to help small businesses advance meaningful health and scientific innovation. But strong science still needs a strong financial foundation.

 

A well-built budget helps show that the company understands the resources required, has thought through the cost structure, and is prepared to manage federal funds responsibly.

Before submitting, applicants should review allowable costs, fee, indirect rates, budget justification, accounting readiness, and Phase II planning. These steps help strengthen the proposal and prepare the company for award management after funding is received.

 

At Peter Witts CPA PC, we help NIH SBIR/STTR applicants and awardees strengthen the financial strategy behind their proposals, from budget planning and indirect rates to accounting system readiness and long-term federal funding growth.

 

Need Help Strengthening Your NIH SBIR/STTR Budget?

If you are preparing an NIH SBIR/STTR application, Peter Witts CPA PC can help you review your budget, indirect rate strategy, fee treatment, cost classifications, accounting readiness, and post-award financial plan.

 

Backed by 35+ years of government contract accounting experience and first-hand DCAA knowledge, our team helps innovators build the financial foundation to pursue funding, manage awards, and grow with confidence.

 

Schedule a strategic consultation with Peter Witts CPA PC to strengthen the financial side of your NIH SBIR/STTR proposal.